Prediction of docetaxel toxicity in older cancer patients: a Bayesian network approach-Reference-Cited by-同舟云学术

Prediction of docetaxel toxicity in older cancer patients: a Bayesian network approach

Published:2019-05-29 Issue:6 Volume:33 Page:679-686
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Khayi Fouzy¹,Lafarge Laurent¹,Terret Catherine²,Albrand Gilles³,Falquet Benoit¹,Culine Stéphane⁴⁵,Gourgou Sophie⁶⁷,Ducher Michel¹⁸,Bourguignon Laurent¹⁹¹⁰^ORCID

Affiliation:

1. Hospices Civils de Lyon Hôpital Pierre Garraud 136 rue du commandant Charcot 69005 Lyon France

2. Department of Medical Oncology Centre Léon Bérard 28 Prom. Léa et Napoléon Bullukian 69008 Lyon France

3. Hospices Civils de Lyon Centre Hospitalier Lyon Sud 165 Chemin du Grand Revoyet 69310 Pierre‐Bénite France

4. Department of Medical Oncology AP‐HP Hôpital Saint‐Louis 1 Avenue Claude Vellefaux 75010 Paris France

5. Paris‐Diderot University Paris France

6. Institut du cancer de Montpellier unité de biométrie, 208, avenue des Apothicaires 34298 Montpellier France

7. Université de Montpellier 163, rue Auguste‐Broussonnet 34090 Montpellier France

8. EMR 3738 Faculté de médecine Lyon‐sud Université Lyon 1 69310 Pierre‐Bénite Lyon France

9. UMR CNRS 5558 Laboratoire de Biométrie et Biologie Évolutive Université Lyon 1 69100 Villeurbanne Lyon France

10. ISPB – Faculté de pharmacie Université Lyon 1 8 Avenue Rockefeller 69008 Lyon France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12476

Reference32 articles.

1. Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

2. Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score

4. Side effects after docetaxel treatment in Taiwanese breast cancer patients with CYP3A4, CYP3A5, and ABCB1 gene polymorphisms

5. Risk-adapted, dose escalation study of weekly docetaxel in the first-line treatment of elderly patients with advanced cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Clinical Decision Support Tool to Find the Best Initial Intravenous Cyclosporine Regimen in Pediatric Hematopoietic Stem Cell Transplantation;The Journal of Clinical Pharmacology;2021-07-20

2. Predicting treatment toxicity in older adults with cancer;Current Opinion in Supportive & Palliative Care;2021-01-04

3. A decision support tool to find the best cyclosporine dose when switching from intravenous to oral route in pediatric stem cell transplant patients;European Journal of Clinical Pharmacology;2020-06-12

4. Frailty and Vulnerability as Predictors of Chemotherapy Toxicity in Older Adults: A Longitudinal Study in Peru;The journal of nutrition, health & aging;2020-06-04

5. Frailty and Vulnerability as Predictors of Chemotherapy Toxicity in Older Adults: A Longitudinal Study in Peru;J NUTR HEALTH AGING;2020